Latest Commercialisation News

GreenHy2 Limited reports a strategic push in Europe with new contracts for its advanced supercapacitor and hydrogen storage technologies, alongside a cash position of $814K and four quarters of funding runway.

Algorae Pharmaceuticals reports significant progress in its AI-driven drug discovery platform, unveiling 24 novel oncology targets and appointing a seasoned Chief Commercial Officer to bolster market readiness.

Decidr AI Industries signals a strategic pivot to AI with a successful $11 million capital raise, new multi-year contracts, and expanded global partnerships, driving early commercial traction and robust e-commerce growth.

Murray Cod Australia Ltd reports a remarkable 192% biomass increase, setting the stage for expanded domestic and international sales from May 2025. The company also advances sustainability certifications and strengthens its board to support growth.

Buxton Resources reports a 345% increase in contained graphite at its Graphite Bull Project and confirms IGO's $5.35 million commitment to expand its Copper Wolf JV interest to 70%.

Osteopore Limited reported a robust 26% quarter-on-quarter revenue increase in Q1 CY25, bolstered by a key Singapore subsidy listing and a strategic pivot away from its dental project to sharpen commercial focus.

Vitrafy Life Sciences reported strong Q3 FY2025 progress, including a successful US Army blood platelet study, a $4.8 million government grant, and strategic US market expansion.

Invictus Energy has secured a three-year extension for its Cabora Bassa Basin licence and gained environmental approval for pilot gas production, setting the stage for expanded exploration and early commercialisation in Zimbabwe.

Reward Minerals Limited has made significant strides in its potash and gypsum projects, securing a new exploration licence and progressing proprietary processing technologies, while evaluating strategic asset relocations and divestments.

Prospect Resources has declared a maiden JORC-compliant copper resource of 107.2 million tonnes at 0.5% copper at its Mumbezhi Project in Zambia, alongside securing a strategic A$15.2 million investment from First Quantum Minerals. This milestone advances the project towards development with Phase 2 drilling planned for Q2 2025.

Zelira Therapeutics has received a $1.15 million cash refund from the Australian Government’s R&D Tax Incentive Scheme, bolstering its working capital to advance clinical development and business operations.

Provaris Energy has launched a capital-lite revenue model designed to generate early cash flow with minimal capital expenditure, alongside securing a major hydrogen supply agreement with Uniper Global Commodities. The company targets first hydrogen deliveries by early 2029, advancing its position in Europe's hydrogen supply chain.